Operation Moonshot

Last updated

Operation Moonshot is a UK government programme to introduce same day mass testing for COVID-19 in England as a way of enabling large gatherings of people to take place in that country while maintaining control over the virus. According to the British Medical Journal , the programme aims to deliver 10 million tests per day by 2021.


The programme has raised concerns because of its expected cost—£100bn according to a leaked government document, which is about three-quarters of the total annual cost of NHS England. Statisticians have moreover warned that given the inaccuracies inherent in any test, mass testing at this scale is liable to cause hundreds of thousands of false positives a day, resulting in very large numbers of people being told that they are infected when they are not. [1]

On 22 October 2020, it was reported that the project had been "subsumed" into the NHS Test and Trace programme run by Dido Harding. [2] As of April 2021, the UK continues to place particularly great emphasis on mass screening using lateral flow tests, available as at-home kits. [3]


The test being proposed for the programme relied on the development of new technology for saliva samples, or swab samples to give a positive or negative reading within minutes, rather than requiring analysis at a laboratory, a process that can take several days. In this way, it is described by media, including the Sheffield Telegraph , as being similar to a pregnancy test. In making a test of this type available, it is projected to negate the need for people to travel to a test centre, something that can require a lengthy journey. [4] At the time of launch, the only proven global technology for COVID-19 testing at the time relied on PCR.


The operation sat within the UK's Department of Health and Social Care (DHSC) response to COVID-19. Initially, it was a separate government program, but eventually was subsumed within the national NHS T&T program. Within the operation, a number of semi-independent teams were established at pace to develop and evaluate COVID-19 technologies that at the time were essentially experimental and unproven.

The remit of each team was to establish and develop a single form of COVID-19 testing. Each teams had an academic lead and focussed on development of a single technology direct LAMP, LAMPore, Mass spectometry, RNA LAMP, point of care PCR, machine-reader lateral flow tests and non-machine based lateral flow tests or rapid tests.

The triage and evaluation plans for machine based technology was led by the UK government's TVG (Technical validation group) and non-machine based technology by the COVID-19 Oversight group with input from Public Health England, [National Health Service]], academic/scientic advisors and DHSC.

LAMP development was led by Prof Keith Godfrey at the University of Southampton. [5]

Oxford Nanopore developed a technology called LAMPore. They have been contracted to deliver millions of tests based on a novel testing method called Transcriptase Loop Amplification (LAMP) that is currently under development; it is hoped that these tests will be able to deliver a result in less than an hour. [1] The government has also paid £323 million for 90 million 20-minute saliva testing kits, chemicals and 600 "Genie HT" machines made by OptiGene, a company based in Horsham, Sussex. [6]


The project was announced at a Downing Street briefing by Boris Johnson, the British Prime Minister, on 9 September 2020. Johnson suggested that mass testing would be a way to allow sports and entertainment venues to reopen again following their closure at the beginning of the pandemic, and for the possibility of people to gather for Christmas parties. [7] Up to that point, scientists had used testing to identify people giving a positive result for the virus, but Johnson outlined what he described as "the 'Moonshot" approach", a test that would show people who are negative and do not pose a potential risk to others, thus giving them a "freedom pass" to attend events and gather with others "in a pre-Covid way". [8] A pilot scheme was announced for indoor and outdoor events in Salford, Greater Manchester, set to begin in October, with plans for a national rollout after that. [8] [9] However, at the time it was unclear what type of tests might be used for mass testing, although it was clear that it might either involve viral antigen detection using lateral flow or Reverse Transcription Loop-mediated Isothermal Amplification. [10] [11] On the 18th of August, at the request of Ministers in the UK Department of Health and Social Care, Public Health England Porton Down and the University of Oxford were requested to develop the clinical research and evaluation infrastructure required to identify the most promising lateral flow devices with the best performance characteristics. [12]

About a week before Johnson's announcement, Matt Hancock, the Secretary of State for Health, had announced that the government would provide funding worth £500m for the development of a saliva test that would produce a result within 20 minutes. Such tests would be used at work places and leisure venues to regularly test those entering the facility. [9] The programme has a target of providing 10 million tests per day by 2021, giving it the capacity to test the entire population of the United Kingdom each week, [13] with GP surgeries and pharmacies utilised to make public access to testing much easier. [14]

Several private sector firms were signed up to the programme, including GSK for the provision of tests, AstraZeneca for laboratory capacity, and Serco and G4S for storage and logistics. [13] One of the government's advisers on rapid testing is Harvard epidemiologist Michael Mina, [15] who suggested a similar "moonshot" in the United States. [16] [17]

By 13 October 2020, the Salford pilot scheme – originally envisaged to involve regular testing of all 254,000 residents – had been significantly scaled back, with government sources saying it would now be "focused on high-risk environments and groups", with testing offered to residents "in some areas of high-density housing". [18] On 19 October 2020, the government announced the start of a pilot of LAMP and lateral flow tests for asymptomatic staff in hospitals in Manchester, Southampton and Basingstoke, with "schools, universities and care homes in the worst-affected regions" to follow at a later date. [19]

On 22 October 2020, it was reported that Operation Moonshot had been and "subsumed" into the NHS Test and Trace (NHSTT) programme run by Dido Harding. [2] A legal letter by government lawyers responding to a bid by the Good Law Project to scrutinise the amounts of government money paid to private contractors said: "The proposal referred to in the Project Moonshot Briefing Pack was developed alongside the existing NHS Test and Trace programme of the Department of Health and Social Care (DHSC). NHSTT's approved 'core' budget was approximately £12.1bn. The substance of the proposal referred to in the Project Moonshot Briefing Pack has since been subsumed within NHSTT, reflecting the fast-moving and constantly evolving policy requirements in the field of testing. It has come to be referred to as part of NHSTT's 'mass testing' programme." [2] Mass testing plans announced envisage weekly tests of up to 10% of the population of England, using millions of 30-minute saliva kits made by the company Innova, "to help control localised outbreaks". [20] Local public health directors would be "eligible to receive on a weekly basis the number of tests equivalent to 10% of their population." [20]

On 5 November 2020’ The Guardian reported that rapid "Direct RT-Lamp" saliva tests made by OptiGene and used in the pilot trial in Salford and Manchester had identified only 46.7% of infections, meaning that in a real-world setting more than half of those infected would be wrongly told that they were virus-free. [6] A DHSC scientist was quoted as saying, "It is incorrect to claim the tests have a low sensitivity, with a recent pilot showing overall technical sensitivity of nearly 80%, rising to over 96% in individuals with a higher viral load, making it important for detecting individuals in the infectious stage. The challenge now is to understand the reasons for the difference in claimed sensitivity in one evaluation versus those in multiple others. [6]


The announcement quickly attracted scrutiny from scientists and health experts, who voiced their doubt as to whether testing several million people daily with a quick turnaround was achievable with laboratory capacity as it stood at the time. [21] Sir Patrick Vallance, the Government's Chief Scientific Adviser said it would be "completely wrong to assume this is a slam dunk that can definitely happen", while Dr Jenny Harries, England's deputy chief medical officer, said the programme's success would depend on how it was handled. [13]

Opposition politicians, including Jonathan Ashworth, the Shadow Secretary of State for Health, questioned the programme's feasibility when the system was already struggling to cope with the volume of tests required of it. [22] Responding to concerns, Grant Shapps, the Secretary of State for Transport, said that the technology to implement the system did not yet exist. [13]

Concerns about programme privatisation and cost

On 10 September 2020, the British Medical Journal quoted a leaked document that forecast the process would cost £100bn—relatively close to the £130bn total annual cost of NHS England. [23] [21] [24] The fact that the plans appeared to involve a substantial proportion of this sum being paid to private businesses attracted comment. Devi Sridhar (University of Edinburgh) said, "There is a case for giving the extra billions to the NHS and asking it to deliver. I have concerns around the bidding process for these contracts. The procurement process isn’t clear, and it allows for a lot of people getting rich off this crisis." [25] Anthony Costello, a former director at the World Health Organization, spoke on Twitter of "waste/corruption on a cosmic scale". [26] Martin McKee, professor of European public health at the London School of Hygiene and Tropical Medicine, wondered what parliamentary scrutiny there would be on spending. [23]

Academics from the universities of Glasgow, St. Andrews and Newcastle, writing in the Journal of the Royal Society of Medicine , said that the decision to separate local public health departments and general practices from the private sector testing system had resulted in "delayed outbreak control", adding: "Despite the failings of this largely private, highly centralised NHS Test and Trace system, it has been reported that the government intends to scale up testing to deliver weekly tests for the whole population. Deloitte and a slew of commercial companies are being contracted to deliver them under Operation Moonshot, a plan to ramp up tests to 10 million a day, at a cost of £100 billion – 70 per cent of the annual NHS budget for England. ... We call on the Westminster government to end privatisation of testing and to reinstate and invest in NHS primary care, public health, and NHS laboratory services, and redirect the resources from the current private testing programmes back into the local primary care, local NHS labs and local public health sector." [27] The Good Law Project initiated legal action against the government, arguing the programme is unlawful because it "involves potentially huge private contracts that may not have been tendered and breaks the government's own value-for-money rules. [28]

The government's own Scientific Advisory Group for Emergencies (SAGE) said, in a Consensus Statement dated 31 August 2020, it was important "to ensure that any mass testing programme provides additional benefit over investing equivalent resources into (i) improving the speed and coverage of NHS Test and Trace for symptomatic cases [...] and (ii) the rate of self-isolation and quarantine for those that test positive (currently estimated to be <20% fully adherent)"; it added that "mass testing can only lead to decreased transmission if individuals with a positive test rapidly undertake effective isolation." [29] [30] Martin McKee said the programme "focuses on only one part of the problem, testing, and says nothing about what will happen to those found positive, a particular concern given the low proportion of those who do adhere to advice to isolate—in part because of the lack of support they are offered." [23] The government said in response to queries that £500 million had been committed so far, and that final costs were as yet unknown. [31]

Danger of false positives in mass testing

Another issue raised by statisticians such as David Spiegelhalter (University of Cambridge) is that mass testing is known to generate false positives. [21] [32] Professor Jon Deeks (University of Birmingham, Cochrane) stated that even if a test were to achieve a very good specificity of 99%, meaning that only 1% of healthy people would be wrongly identified as infected, testing the entire population of the UK would result in over half a million people being told they had to self-isolate, along with their contacts. [23] False positives might end up outnumbering actual infected people at a ratio of 1,000 to 1, according to Deeks' estimates. [1] A paper published by SAGE suggested the programme could lead to 41% of the UK population having to self-isolate needlessly within six months due to false positives, and warned of potential school closures and workers' losing their wages through incorrect test results. [33] On 11 September 2020, these concerns were echoed by the Royal Statistical Society, which warned in a letter to The Times that the plan "does not seem to take account of fundamental statistical issues" and risked "causing personal and economic harm to tens of thousands of people." [31] [34]

Danger of false negatives in home testing

Angela Raffle and Mike Gill, writing in the British Medical Journal in April 2021, called the UK's mass screening approach "a misguided policy, unlikely to reduce transmission", arguing that people might be "tempted" to use home kits rather than go for the more sensitive PCR test, leaving them "falsely reassured". [3] [35]


Academics seeing the leaked documents expressed concern about the apparent lack of input "from scientists, clinicians, and public health and testing and screening experts." [23] On 11 September 2020, The Guardian reported that the National Screening Committee, which normally advises government and the NHS on "all aspects of population screening", had not been consulted on the plans. [29] Allyson Pollock (Newcastle University) stated she found this incomprehensible as many UK experts were available. [29] Jon Deeks added, "There is massive cause for concern that there is no screening expertise evident in the documents. They are written by management consultants." [29]

Related Research Articles

Public Health England Executive agency in UK health system

Public Health England (PHE) is an executive agency of the Department of Health and Social Care in the United Kingdom which began operating on 1 April 2013 to protect and improve health and wellbeing and reduce health inequalities. Its formation came as a result of the reorganisation of the National Health Service (NHS) in England outlined in the Health and Social Care Act 2012. It took on the role of the Health Protection Agency, the National Treatment Agency for Substance Misuse and a number of other health bodies. It was an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy.

Simon Stevens British health manager and civil servant

Simon Laurence Stevens, Baron Stevens of Birmingham, KBE is a British health manager and public policy analyst serving as the eighth Chief Executive of the National Health Service in England since 2014. He previously served as an executive at the UnitedHealth Group from 2004 to 2014, an American for-profit managed health care company which offers health care products and insurance services. A former member of the Labour Party, he was a councillor in the London Borough of Lambeth from 1998 to 2002.

COVID-19 testing Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or of antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

COVID-19 pandemic in the United Kingdom Viral pandemic, 2020–

The COVID-19 pandemic in the United Kingdom is part of the worldwide pandemic of coronavirus disease 2019. The virus reached the UK in late January 2020. As of 26 June 2021, there had been more than 4.7 million confirmed cases and 128,330 deaths among people who had recently tested positive – the world's nineteenth-highest death rate by population and the second-highest death toll in Europe after Russia. There has been some disparity between the outbreak's severity in England, Scotland, Wales and Northern Ireland – health in the UK is devolved, with each country having its own publicly funded healthcare system and government.

COVID-19 pandemic in Scotland Ongoing COVID-19 viral pandemic in Scotland

The COVID-19 pandemic was first confirmed to have spread to Scotland on 1 March 2020 with the positive COVID-19 test of a male Tayside resident who had recently travelled between Scotland and northern Italy. The first reported case of community transmission was on 11 March 2020 and the first reported coronavirus death in Scotland was on 13 March 2020.

Operation Rescript British military operation to tackle the COVID-19 pandemic

Operation Rescript is the code name for the British military operation to help tackle the ongoing COVID-19 pandemic in the United Kingdom. It has been described as the UK's "biggest ever homeland military operation in peacetime" by the Ministry of Defence (MOD), involving up to 23,000 personnel within a specialist task force, named the COVID Support Force (CSF). The support is given at the request of the UK government, its devolved administrations and civil authorities through the Military aid to the civil authorities (MACA) mechanism.

COVID-19 pandemic in England Ongoing COVID-19 viral pandemic in England

The COVID-19 pandemic was first confirmed to have spread to England with two cases among Chinese nationals staying in a hotel in York on 31 January 2020. The two main public bodies responsible for health in England are NHS England and Public Health England. NHS England oversees the budget, planning, delivery and day-to-day operation of the commissioning side of the NHS in England while PHE's mission is "to protect and improve the nation’s health and to address inequalities". As of 10 July 2021, there have been 4,422,370 total cases and 112,906 deaths in England. In January 2021 it was estimated around 22% of people in England have had COVID-19.

British government response to the COVID-19 pandemic UK government response to COVID-19

Her Majesty's Government responded to the COVID-19 pandemic in the United Kingdom in various ways. Because of devolution, following the arrival of COVID-19 on 31 January 2020, the different home nations' administrative responses to the pandemic have been different to one another; the Scottish Government, the Welsh Government, and the Northern Ireland Executive have produced different policies to those that apply in England. The National Health Service is the publicly funded healthcare system of Britain, and has separate branches for each of its four nations.

Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020) Daily UK events related to the 2020 pandemic

The following is a timeline of the COVID-19 pandemic in the United Kingdom from January 2020 to July 2020.

NHS COVID-19 UK contact tracing app for COVID-19

NHS COVID-19 is a voluntary contact tracing app for monitoring the spread of the COVID-19 pandemic in England and Wales. It has been available since 24 September 2020 for Android and iOS smartphones, and can be used by anyone aged 16 or over.

Margaret McCartney general practitioner, writer and broadcaster

Margaret Mary McCartney is a general practitioner, freelance writer and broadcaster based in Glasgow, Scotland. McCartney is a vocal advocate for evidence-based medicine. McCartney was a regular columnist at the British Medical Journal. She regularly writes articles for The Guardian and currently contributes to the BBC Radio 4 programme, Inside Health. She has written three popular science books, The Patient Paradox, The State of Medicine and Living with Dying. During the COVID-19 pandemic, McCartney contributed content to academic journals and broadcasting platforms, personal blog, and social media to inform the public and dispel myths about coronavirus disease.

NHS Test and Trace Government COVID-19 agency in England

NHS Test and Trace is a government-funded service in England, established in 2020 to track and help prevent the spread of COVID-19. Despite its name, the programme is not in fact run by the NHS but is part of the UK Health Security Agency; the service and the agency are headed by Jenny Harries.

The following is a timeline of the COVID-19 pandemic in England from January 2020 to June 2020. There are significant differences in the legislation and the reporting between the countries of the UK: England, Scotland, Northern Ireland, and Wales.

UK Health Security Agency Executive agency in UK health system

The UK Health Security Agency (UKHSA) is a government agency in the United Kingdom, responsible since April 2021 for UK-wide public health protection and infectious disease capability, and replacing Public Health England. It is an executive agency of the Department of Health and Social Care (DHSC).

Professor Gabriel John Scally FFPHM is a Northern Irish public health physician and a former regional director of public health (RDPH) for the south west of England. He is a visiting professor of public health at the University of Bristol and president of the section of epidemiology and public health of the Royal Society of Medicine. Previously he was professor of public health and planning, and director of the World Health Organisation (WHO) Collaborating Centre for Healthy Urban Environments, both at the University of the West of England (UWE), and chair of the Trustees of the Soil Association. He is a member of the Independent SAGE group, formed during the COVID-19 pandemic in 2020.

Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020) Daily UK events related to the 2020 pandemic

The following is a timeline of the COVID-19 pandemic in the United Kingdom from July 2020 to December 2020.

In response to the COVID-19 pandemic in the United Kingdom, from March 2020 the British government decided to rapidly place contracts and recruit a number of individuals, with shortages of personal protective equipment being a particular political issue for the second Johnson ministry. This led to a number of contracts being awarded without a competitive tendering process, and friends of political figures and people who had made political donations being "fast-tracked" into contracts. This led to accusations of cronyism or a "chumocracy", with Transparency International UK finding that a fifth of contracts "raised red flags for possible corruption".

COVID-19 vaccination in the United Kingdom Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for COVID-19 during the pandemic in the United Kingdom. The UK's vaccination rollout was the world's first mass immunisation programme for the disease when it began on 8 December 2020 after Margaret Keenan received her first dose of two. As of 15 July 2021, 46,159,145 first doses and 35,543,321 second doses of a vaccine had been administered across the UK.

The following is a timeline of the COVID-19 pandemic in England from July 2020 to December 2020. There are significant differences in the legislation and the reporting between the countries of the UK: England, Scotland, Northern Ireland, and Wales.

COVID-19 rapid antigen test

COVID-19 rapid antigen tests, also frequently called COVID-19 lateral flow tests, are rapid antigen tests used to detect SARS-COV-2 infection (COVID-19). They are quick to implement with minimal training, offered significant cost advantages, costing a fraction of other forms of COVID-19 testing and give users a result within 5–30 minutes. However, they have a high false negative rate. Rapid antigen tests are used in several countries as part of mass testing or population-wide screening approaches. They are thought to be valuable for identifying individuals who are asymptomatic and could potentially spread the virus to other people, who would otherwise not know they were infected. This differs from other forms of COVID-19 testing, such as PCR, that are generally seen to be a useful test for symptomatic individuals, as they have a higher sensitivity and can more accurately identify cases.


  1. 1 2 3 Cox, David (12 September 2020). "The big problem with Operation Moonshot? False positives". Wired UK via www.wired.co.uk.
  2. 1 2 3 "£100bn budget for Covid Operation Moonshot dumped as project swallowed up by Test and Trace". 22 October 2020.
  3. 1 2 "Mass testing for Covid could increase transmission – experts".
  4. "Here's what you need to know about Boris Johnson's mass testing plan Operation Moonshot". www.sheffieldtelegraph.co.uk. Retrieved 12 September 2020.
  5. "Clinical evaluation confirms accuracy of LAMP test". GOV.UK. Retrieved 24 December 2020.
  6. 1 2 3 "Operation Moonshot: Rapid Covid test missed over 50% of cases in pilot". 5 November 2020.
  7. "Coronavirus: New virus measures 'not a second lockdown'". BBC News. BBC. 9 September 2020. Retrieved 9 September 2020.
  8. 1 2 "PM's 'Operation Moonshot' testing plan criticised by top doctors". Evening Standard. 9 September 2020. Retrieved 10 September 2020.
  9. 1 2 Robson, Steve (9 September 2020). "What is Operation Moonshot and could it really work?". Manchester Evening News. Retrieved 10 September 2020.
  10. Mahase, Elisabeth (16 September 2020). "Operation Moonshot: Testing plan relies on technology that does not exist". BMJ. 370: m3585. doi: 10.1136/bmj.m3585 . ISSN   1756-1833. PMID   32938606. S2CID   221712524.
  11. "Coronavirus: What are the challenges of mass testing?". BBC News. 11 September 2020. Retrieved 25 November 2020.
  12. "First wave of non-machine based lateral flow technology (LFT) assessment". GOV.UK. Retrieved 25 November 2020.
  13. 1 2 3 4 "Boris Johnson's plan for mass coronavirus testing raises concern". The Independent. 10 September 2020. Retrieved 10 September 2020.
  14. Mahase, Elisabeth (10 September 2020). "Operation Moonshot: GP clinics could be used to improve access to covid-19 tests". British Medical Journal. Retrieved 10 September 2020.
  15. Booth, William; Adam, Karla (12 September 2020). "Boris Johnson's 'Operation Moonshot' envisions weekly coronavirus tests for every person in Britain". Washington Post. Retrieved 19 September 2020.
  16. Meyer, Robinson; Madrigal, Alexis C. (14 August 2020). "The Plan That Could Give Us Our Lives Back". The Atlantic. Retrieved 19 September 2020.
  17. Siddons, Andrew (13 August 2020). "Top health official argues against widespread COVID-19 testing approach". Roll Call. Retrieved 19 September 2020.
  18. Partington, Richard; Pidd, Helen (13 October 2020). "'Operation Moonshot': doubts over UK's Covid test ambitions after trial scaled back" . Retrieved 13 October 2020.
  19. "Operation Moonshot: Pilot of rapid Covid tests under way in NHS hospitals". 19 October 2020.
  20. 1 2 "10% of England's population could be tested for Covid-19 every week". 28 October 2020.
  21. 1 2 3 "Concerns over PM's mass virus testing plans". BBC News. 10 September 2020. Retrieved 10 September 2020.
  22. "Matt Hancock heckled by opposition MPs as he outlines 'Operation Moonshot'". 10 September 2020. Retrieved 10 September 2020.
  23. 1 2 3 4 5 Gareth Iacobucci; Rebecca Coombes (9 September 2020). "Covid-19: Government plans to spend £100bn on expanding testing to 10 million a day". British Medical Journal. 370: m3520. doi: 10.1136/bmj.m3520 . PMID   32907851.
  24. "'Operation Moonshot' mass Covid testing plans could cost up to £100bn". ITV News. 10 September 2020. Retrieved 10 September 2020.
  25. "'Horrified' scientists slam Boris Johnson's £100bn Moonshot plan". The National. Retrieved 11 September 2020.
  26. "Coronavirus: 'Waste and corruption on a cosmic scale': Plans for 10 million COVID-19 tests attacked". Sky News. Retrieved 11 September 2020.
  27. Staff (28 October 2020). "10,000 people a day could receive false positives in Operation Moonshot, researchers say". The Telegraph. Retrieved 29 October 2020.
  28. Robert Booth (18 September 2020). "UK government faces legal action over 'moonshot' Covid testing project". The Guardian. Retrieved 19 September 2020.
  29. 1 2 3 4 Booth, Robert (11 September 2020). "UK health screening advisers not involved in 'moonshot' Covid plan" . Retrieved 12 September 2020 via www.theguardian.com.
  30. "Multidisciplinary Task and Finish Group on Mass Testing – Consensus Statement for SAGE" (PDF). gov.uk. 31 August 2020. Retrieved 12 September 2020.
  31. 1 2 Chris Smyth; Becky McCall (11 September 2020). "Coronavirus: Experts criticise Johnson over 'dangerous' moonshot mass testing plan". The Times. Retrieved 11 September 2020.
  32. Samuel Lovett (11 September 2020). "Coronavirus: Operation Moonshot 'not feasible' and 'massive gamble,' health experts warn". The Independent. Retrieved 12 September 2020.
  33. Mendick, Robert; Donnelly, Laura (10 September 2020). "Moonshot testing plan 'could send 28 million into needless self-isolation'" . The Telegraph. Telegraph Media Group. Retrieved 10 September 2020.
  34. "Times letters". The Times. 11 September 2020. Retrieved 11 September 2020.
  35. https://www.bmj.com/content/bmj/373/bmj.n1058.full.pdf